एपीए उद्धरण

Sun, Y., Bailey, C., Whitehead, C., Sebolt-Leopold, J., & Chandra, J. (2019). THER-29. NOVEL DUAL EGFR/PI3-KINASE INHIBITORS SHOW ENHANCED POTENCY, STRONGER PATHWAY SUPPRESSION AND TARGETING OF METABOLIC PROPERTIES IN PEDIATRIC AND ADULT HIGH GRADE GLIOMA MODELS THAN SINGLE KINASE INHIBITORS. Neuro Oncol.

शिकागो स्टाइल उद्धरण

Sun, Yusha, Cavan Bailey, Christopher Whitehead, Judith Sebolt-Leopold, और Joya Chandra. "THER-29. NOVEL DUAL EGFR/PI3-KINASE INHIBITORS SHOW ENHANCED POTENCY, STRONGER PATHWAY SUPPRESSION AND TARGETING OF METABOLIC PROPERTIES IN PEDIATRIC AND ADULT HIGH GRADE GLIOMA MODELS THAN SINGLE KINASE INHIBITORS." Neuro Oncol 2019.

एमएलए उद्धरण

Sun, Yusha, et al. "THER-29. NOVEL DUAL EGFR/PI3-KINASE INHIBITORS SHOW ENHANCED POTENCY, STRONGER PATHWAY SUPPRESSION AND TARGETING OF METABOLIC PROPERTIES IN PEDIATRIC AND ADULT HIGH GRADE GLIOMA MODELS THAN SINGLE KINASE INHIBITORS." Neuro Oncol 2019.